The ACE Scholars Program was founded by an ASU researcher based on her experience working in labs as a studentContinue reading
Author Archive: AZBio
Barrow Receives DoD Grant to Repurpose Existing Drug for ALS
The United States Department of Defense (DoD) has awarded Barrow Neurological Institute an $840,000 grant to repurpose an existing class of drugs to target a specific molecular pathway that scientists have recently linked to ALS and other neurodegenerative diseases.
The two-year Therapeutic Idea Award—led by David Medina, PhD, an assistant professor in the Bowser Laboratory in the Department of Translational Neuroscience at Barrow—aims to increase our understanding of the role of m6A dysregulation in ALS and determine whether targeting this dysregulation with small-molecule drugs can reduce progression of the disease.
AZBioPEERS: How to Access Small Business Grants & Commercialization Resources at the National Cancer Institute
Are you developing a promising cancer-focused technology and seeking funding to advance it toward commercialization? Join the National Cancer Institute’s Small Business Innovation Research Development Center for an informational webinar on how early-stage companies, academic spinouts, and entrepreneurial researchers can access funding and commercialization support from the National Cancer Institute (NCI). Continue reading
Banner Alzheimer’s Institute celebrates 20 years of pioneering research, compassionate care
Two decades of groundbreaking discoveries in prevention, treatment & detectionContinue reading
Janko Z. Nikolich, MD, PhD, Honored as Regents Professor at the U of A’s 2026 Luminaries Outstanding Faculty Awards
The awards showcased the extraordinary talent shaping the future of science, arts, innovation and education at the University of ArizonaContinue reading
BIO Unveils Seven-Point Plan to Secure America’s Leadership in the Biotech Century
Action plan outlines the policies needed to ensure that the biotechnology sector remains a driving force for America’s health, prosperity, national security, and geopolitical strengthContinue reading
BD Names Bridget Bagnato Worldwide President of Peripheral Intervention
FRANKLIN LAKES, N.J., Nov. 4, 2026 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Bridget Bagnato has been appointed worldwide president of its Peripheral Intervention business unit, effective November 16.
Based at Peripheral Intervention’s headquarters in Tempe, Arizona, Bagnato will be responsible for driving the business unit’s global strategic, operational and commercial performance. She will report to Peter Menziuso, executive vice president and president of the Interventional segment.Continue reading
CMS Publishes Final Rule on Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program
In August 2o26, the Arizona Bioindustry Association (AZBio) joined over 11,ooo stakeholders from across the country in submitting comments on the CMS Proposed Rule on Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program. On November 5, 2026, CMS published the final rule. Continue reading
BIO, Biocom, and California Life Sciences Sue to Block CMS GLOBE Rule
Complaint argues HHS and CMS exceeded statutory authority; rule puts patient access, investment in future innovation, and America’s long-term biotechnology leadership at risk.Continue reading